XL647 News
Most Popular XL647 Story
Exelixis garners $71M in public offering
Exelixis has rounded up slightly more than $71 million on the close of its public offering. Just days before the offering Exelixis reported encouraging interim data from an ongoing Phase II trial Read more...
Latest Headlines
- September 13, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
